These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16283122)

  • 41. Comparative intracellular growth of difficult-to-grow and other mycobacteria in a macrophage cell line.
    Rastogi N; Blom-Potar MC; David HL
    Acta Leprol; 1989; 7 Suppl 1():156-9. PubMed ID: 2503976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mycobacterial infections in man: bacteriological, clinical and epidemiological evaluation (author's transl)].
    Mandler F; Velluti G
    Ann Sclavo; 1976; 18(2):268-76. PubMed ID: 1015870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease.
    Chan ED; Bai X; Kartalija M; Orme IM; Ordway DJ
    Am J Respir Cell Mol Biol; 2010 Oct; 43(4):387-93. PubMed ID: 20081053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rat polyarthritis: induction with adjuvants constituted with mycobacteria (and oils) from the environment.
    Whitehouse MW
    J Rheumatol; 1982; 9(4):494-501. PubMed ID: 7131451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cell-cell interactions during formation and reactivation of "nonculturable" mycobacteria].
    Salina EG; Vostroknutova GN; Shleeva MO; Kaprel'iants AS
    Mikrobiologiia; 2006; 75(4):502-8. PubMed ID: 17025176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Essential Roles of PPARs in Lipid Metabolism during Mycobacterial Infection.
    Tanigawa K; Luo Y; Kawashima A; Kiriya M; Nakamura Y; Karasawa K; Suzuki K
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Non-tuberculous Mycobacteria: epidemiologic importance and current pathogenicity].
    De Haller R; Piguet JD; De Haller J
    Schweiz Med Wochenschr; 1983 Jan; 113(3):80-7. PubMed ID: 6338585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the Mycobacteria Growth Indicator Tube for the bacteriological diagnosis of tuberculosis.
    Diraa O; Fdany K; Boudouma M; Elmdaghri N; Benbachir M
    Int J Tuberc Lung Dis; 2003 Oct; 7(10):1010-2. PubMed ID: 14552573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Water soluble complex of palmitic acid in media for cultivation of leprosy-derived psychrophilic mycobacteria from Mycobacterium leprae infected tissues.
    Kátó L; Szejtli J; Szente L
    Acta Microbiol Hung; 1993; 40(1):47-58. PubMed ID: 8304006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of 3 culture media for isolating mycobacteria from extrapulmonary samples].
    Esteban J; Valero-Moratalla ML; Jiménez-Arriero M; Jiménez-Castillo P; Soriano F
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):592-5. PubMed ID: 8808475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Models of the within-host dynamics of persistent mycobacterial infections.
    Antia R; Koella JC; Perrot V
    Proc Biol Sci; 1996 Mar; 263(1368):257-63. PubMed ID: 8920248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of NaOH-N-acetyl cysteine and sulfuric acid decontamination methods for recovery of mycobacteria from clinical specimens.
    Buijtels PC; Petit PL
    J Microbiol Methods; 2005 Jul; 62(1):83-8. PubMed ID: 15823396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virulence, biochemistry, morphology and host-interacting properties of detergent-free cultured mycobacteria: An update.
    Leisching G; Pietersen RD; Wiid I; Baker B
    Tuberculosis (Edinb); 2016 Sep; 100():53-60. PubMed ID: 27553410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mycobacterium fortuitum mastoiditis.
    Austin WK; Lockey MW
    Arch Otolaryngol; 1976 Sep; 102(9):558-60. PubMed ID: 962700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 'Emerging' mycobacteria in South Africa.
    van Helden PD; Parsons SD; Gey van Pittius NC
    J S Afr Vet Assoc; 2009 Dec; 80(4):210-4. PubMed ID: 20458859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucosa-associated lymphoid tissues as sites for uptake, carriage and excretion of tubercle bacilli and other pathogenic mycobacteria.
    Lugton I
    Immunol Cell Biol; 1999 Aug; 77(4):364-72. PubMed ID: 10457205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of virulence determinants in pathogenic mycobacteria.
    Clark-Curtiss JE
    Curr Top Microbiol Immunol; 1998; 225():57-79. PubMed ID: 9386328
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms of persistence of mycobacteria.
    Britton WJ; Roche PW; Winter N
    Trends Microbiol; 1994 Aug; 2(8):284-8. PubMed ID: 7981971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pathogenicity of atypical mycobacteria for guinea-pigs.
    Haas H; Rosenmann E; Weber D; Sacks TG
    Pathol Microbiol (Basel); 1968; 31(4):193-201. PubMed ID: 5667672
    [No Abstract]   [Full Text] [Related]  

  • 60. [The problem of mycobacterial infections and the importance of atypical or "anonymous" mycobacteria in human microbiology and pathology. (Literature survey)].
    Togunova AI
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):99-102. PubMed ID: 5337070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.